Cargando…
The Mitochondrial Genes BAK1, FIS1 and SFN are Linked with Alterations in Mitochondrial Membrane Potential in Barrett’s Esophagus
Barrett’s esophagus and esophageal cancer lack prognostic markers that allow the tailoring of personalized medicine and biomarkers with potential to provide insight into treatment response. This study aims to characterize mitochondrial function across the metaplasia-dysplasia-adenocarcinoma disease...
Autores principales: | Phelan, James J., MacCarthy, Finbar, O’Toole, Dermot, Ravi, Narayanasamy, Reynolds, John V., O’Sullivan, Jacintha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6275077/ https://www.ncbi.nlm.nih.gov/pubmed/30404157 http://dx.doi.org/10.3390/ijms19113483 |
Ejemplares similares
-
Changes in mitochondrial stability during the progression of the Barrett’s esophagus disease sequence
por: O’Farrell, N. J., et al.
Publicado: (2016) -
Differential Expression Profiles of Oxidative Stress Levels, 8-oxo-dG and 4-HNE, in Barrett’s Esophagus Compared to Esophageal Adenocarcinoma
por: O’Farrell, Naoimh J., et al.
Publicado: (2019) -
Real-time metabolic profiling of oesophageal tumours reveals an altered metabolic phenotype to different oxygen tensions and to treatment with Pyrazinib
por: Buckley, Amy M., et al.
Publicado: (2020) -
Histopathology in Barrett Esophagus and Barrett Esophagus-Related Dysplasia
por: Grin, Andrea, et al.
Publicado: (2014) -
Role of Mitochondrial Markers in Improved Detection and Risk-Stratification in Barrett’s Esophagus Patients
por: Grewal, Udhayvir S., et al.
Publicado: (2019)